Neurology

Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD

Ramón Novell MD, Susanna Esteba-Castillo PhD, Emili Rodriguez PhD

Article Type

Original Research

Published

Gamalate B6 was evaluated in patients
with borderline intellectual functioning or mild intellectual
development disability and found to be effective and well tolerated for ADHD and challenging behavior.

Read more

Anti-NMDA receptor encephalitis: a case study and illness overview

Brian Ford MD, Alex McDonald MD, Shilpa Srinivasan MD, DFAPA

Article Type

Review

Published

This review on anti-N-methyl D-aspartate (NMDA) receptor (anti-NMDAR) encephalitis provides a case presentation and the timeline of symptoms seen over the course of the illness. Key findings in the literature about anti-NMDAR encephalitis are highlighted to facilitate diagnostic consideration and treatment.

Read more

Use of botulinum toxin for movement disorders

Carlos Henrique Ferreira Camargo MD, MSc, PhD, Hélio Afonso Ghizoni Teive MD, MSc, PhD

Article Type

Review

Published

The aim of this review is to present the new and well-established uses of botulinum toxin for movement disorders.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.